166 related articles for article (PubMed ID: 37987379)
21. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Chang UI; Kim HW; Wie SH
Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
[TBL] [Abstract][Full Text] [Related]
23. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.
Gupta K; Hooton TM; Stamm WE
Ann Intern Med; 2001 Jul; 135(1):41-50. PubMed ID: 11434731
[TBL] [Abstract][Full Text] [Related]
24. The current management strategies for community-acquired urinary tract infection.
Hooton TM
Infect Dis Clin North Am; 2003 Jun; 17(2):303-32. PubMed ID: 12848472
[TBL] [Abstract][Full Text] [Related]
25. Community-acquired antibiotic resistance in urinary isolates from adult women in Canada.
McIsaac WJ; Mazzulli T; Permaul J; Moineddin R; Low DE
Can J Infect Dis Med Microbiol; 2006 Nov; 17(6):337-40. PubMed ID: 18382648
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
27. Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Davis WH; Magee MR; Monks SM; Geno KA; Crawford SB
Am J Emerg Med; 2022 Nov; 61():12-17. PubMed ID: 36027632
[TBL] [Abstract][Full Text] [Related]
28. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
Langner JL; Chiang KF; Stafford RS
Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
[TBL] [Abstract][Full Text] [Related]
29. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factor analysis of resistant Escherichia coli urinary tract infections in the emergency department.
Bailey AM; Weant KA; Baker SN
Pharm Pract (Granada); 2013 Apr; 11(2):96-101. PubMed ID: 24155856
[TBL] [Abstract][Full Text] [Related]
31. Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women.
Wie SH; Kim HW; Chang UI
Clin Microbiol Infect; 2014 Nov; 20(11):1211-8. PubMed ID: 24909648
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
[TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
[TBL] [Abstract][Full Text] [Related]
34. Comparison of antimicrobial resistance in patients with obstructive pyelonephritis associated with ureteral stones and uncomplicated pyelonephritis.
Jang YR; Won J; Han J; Chung W; Ahn SJ
Medicine (Baltimore); 2022 Aug; 101(34):e30376. PubMed ID: 36042611
[TBL] [Abstract][Full Text] [Related]
35. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
Caterino JM; Weed SG; Espinola JA; Camargo CA
Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
[TBL] [Abstract][Full Text] [Related]
36. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
37. Changes in Clinical Characteristics of Community-Acquired Acute Pyelonephritis and Antimicrobial Resistance of Uropathogenic
Kwon KT; Kim B; Ryu SY; Wie SH; Kim J; Jo HU; Park SY; Hong KW; Kim HI; Kim HA; Kim MH; Bae MH; Sohn YH; Kim J; Lee Y; Pai H
Antibiotics (Basel); 2020 Sep; 9(9):. PubMed ID: 32961887
[TBL] [Abstract][Full Text] [Related]
38. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
39. Cephalosporins for the treatment of uncomplicated pyelonephritis: A systematic review.
Zimmerman DE; Tomas M; Miller D; Tomcsanyi L; Signorella C; Montepara CA; Covvey JR; Guarascio AJ
J Am Pharm Assoc (2003); 2023; 63(5):1461-1471. PubMed ID: 37414282
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance patterns in outpatient urinary tract infections--the constant need to revise prescribing habits.
Bosch FJ; van Vuuren C; Joubert G
S Afr Med J; 2011 May; 101(5):328-31. PubMed ID: 21837876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
